Occupational Exposure to Ultrafine Particles and Placental Histopathological Lesions: A Retrospective Study about 130 Cases.


Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
02 12 2021
Historique:
received: 07 11 2021
revised: 24 11 2021
accepted: 25 11 2021
entrez: 10 12 2021
pubmed: 11 12 2021
medline: 15 12 2021
Statut: epublish

Résumé

Ultrafine particles (UFPs) are particles smaller than 100 nanometers that are produced unintentionally during human activities or natural phenomena. They have a higher biological reactivity than bigger particles and can reach the placenta after maternal exposure. One study has shown an association between maternal occupational exposure to UFPs and fetal growth restriction. Yet few studies have focused on the effects of UFP exposure on placental histopathological lesions. The aim of this study was to investigate the association between maternal occupational exposure to UFPs and histopathological lesions of their placenta. The analyses were based on data from the ARTEMIS Center. A job-exposure matrix was used to assess occupational exposure to UFPs. The histopathological placental exam was performed by two pathologists who were blinded to the exposure of each subject. The examination was conducted in accordance with the recommendations of the Amsterdam consensus. The study sample included 130 placentas (30 exposed, 100 unexposed). Maternal occupational exposure to UFPs during pregnancy is significantly associated with placental hypoplasia (the phenomenon affected 61% of the exposed patients and 34% of the unexposed ones,

Identifiants

pubmed: 34886445
pii: ijerph182312719
doi: 10.3390/ijerph182312719
pmc: PMC8656674
pii:
doi:

Substances chimiques

Air Pollutants 0
Particulate Matter 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Ann Work Expo Health. 2017 Aug 1;61(7):749-758
pubmed: 28810681
Placenta. 2013 Jan;34(1):62-6
pubmed: 23174148
Biomed Res Int. 2017;2017:6073167
pubmed: 28466013
Exp Mol Med. 2020 Mar;52(3):318-328
pubmed: 32203103
Nano Lett. 2006 Aug;6(8):1794-807
pubmed: 16895376
Ann Work Expo Health. 2021 Jun 12;65(5):516-527
pubmed: 33637984
Sci Total Environ. 2018 Apr 1;619-620:834-841
pubmed: 29734629
Int J Environ Res Public Health. 2014 Oct 21;11(10):10951-66
pubmed: 25337942
Part Fibre Toxicol. 2020 Nov 2;17(1):56
pubmed: 33138843
ACS Nano. 2011 Jun 28;5(6):4624-33
pubmed: 21615177
Arch Pathol Lab Med. 2016 Jul;140(7):698-713
pubmed: 27223167
J Ultrasound Med. 2003 Dec;22(12):1341-7
pubmed: 14682422
Environ Int. 2016 Jul-Aug;92-93:471-7
pubmed: 27164556
Nat Commun. 2019 Sep 17;10(1):3866
pubmed: 31530803
Environ Int. 2017 Oct;107:216-226
pubmed: 28753483
Int J Environ Res Public Health. 2020 Jan 21;17(3):
pubmed: 31973110
Clin Epigenetics. 2019 Sep 17;11(1):124
pubmed: 31530287
Semin Reprod Med. 2011 May;29(3):187-96
pubmed: 21710395
Environ Res. 2020 Jun;185:109394
pubmed: 32247149
J Alzheimers Dis. 2019;68(4):1371-1390
pubmed: 31006689
Environ Int. 2019 Jan;122:322-329
pubmed: 30459064
J Matern Fetal Neonatal Med. 2018 Mar;31(6):817-821
pubmed: 28282763
Exp Mol Med. 2020 Mar;52(3):311-317
pubmed: 32203102
Occup Environ Med. 2001 Mar;58(3):211-6, 199
pubmed: 11171936
Part Fibre Toxicol. 2016 Jul 26;13(1):39
pubmed: 27460165
Part Fibre Toxicol. 2013 Jun 06;10:21
pubmed: 23742083
Environ Health Perspect. 2017 Oct 10;125(10):106002
pubmed: 29017987
Arch Pathol Lab Med. 1997 May;121(5):449-76
pubmed: 9167599
Risk Anal. 2010 Nov;30(11):1634-44
pubmed: 20626687

Auteurs

Anaïs Pasquiou (A)

Department of Pathology, Bordeaux University Hospital, 33076 Bordeaux, France.

Fanny Pelluard (F)

Department of Pathology, Bordeaux University Hospital, 33076 Bordeaux, France.
BaRITOn, INSERM U1053, University of Bordeaux, 33076 Bordeaux, France.

Guyguy Manangama (G)

ARTEMIS Center, Bordeaux University Hospital, 33076 Bordeaux, France.
Bordeaux Population Health Research Center, Inserm UMR1219-EPICENE, University of Bordeaux, 33076 Bordeaux, France.

Patrick Brochard (P)

ARTEMIS Center, Bordeaux University Hospital, 33076 Bordeaux, France.
Bordeaux Population Health Research Center, Inserm UMR1219-EPICENE, University of Bordeaux, 33076 Bordeaux, France.

Sabyne Audignon (S)

ARTEMIS Center, Bordeaux University Hospital, 33076 Bordeaux, France.
Bordeaux Population Health Research Center, Inserm UMR1219-EPICENE, University of Bordeaux, 33076 Bordeaux, France.

Loïc Sentilhes (L)

Department of Obstetrics and Gynecology, Bordeaux University Hospital, 33076 Bordeaux, France.

Fleur Delva (F)

ARTEMIS Center, Bordeaux University Hospital, 33076 Bordeaux, France.
Bordeaux Population Health Research Center, Inserm UMR1219-EPICENE, University of Bordeaux, 33076 Bordeaux, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH